NCT06547918View on ClinicalTrials.gov

SmartAdjust 2.0 System With Type 1 and Type 2 Diabetes

NARecruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

July 18, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Diabetes Mellitus
Interventions
DEVICE

Omnipod 5 SA2.0 System

The Omnipod 5 SA2.0 System provides automated insulin delivery based on Continuous Glucose Monitoring (CGM) values.

Trial Locations (2)

6021

RECRUITING

Wellington Regional Hospital, Wellington

8011

RECRUITING

University of Otago, Christchurch, Christchurch

Sponsors
All Listed Sponsors
lead

Insulet Corporation

INDUSTRY

NCT06547918 - SmartAdjust 2.0 System With Type 1 and Type 2 Diabetes | Biotech Hunter | Biotech Hunter